Protocol Ledger

NCT03757949 · Phase III · ACTIVE NOT RECRUITING

Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery

Interventional Phase III clinical trial protocol NCT03757949 sponsored by SWOG Cancer Research Network in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-03-05 Enrollment: 203 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03757949
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)203 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03757949
Protocol FieldVerified Registry Value
NCT IdentifierNCT03757949
Consolidated Lead SponsorSWOG Cancer Research Network
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment203 participants (ACTUAL)
Registered Start Date2019-03-05
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI